- Home
- SLN vs WALD Comparison
SLN vs WALD Comparison
Compare SLN & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLN
- WALD
- Stock Information
- Founded
- SLN 1994
- WALD 1988
- Country
- SLN United Kingdom
- WALD United Kingdom
- Employees
- SLN N/A
- WALD N/A
- Industry
- SLN Biotechnology: Pharmaceutical Preparations
- WALD Package Goods/Cosmetics
- Sector
- SLN Health Care
- WALD Consumer Discretionary
- Exchange
- SLN Nasdaq
- WALD Nasdaq
- Market Cap
- SLN 352.2M
- WALD 404.2M
- IPO Year
- SLN N/A
- WALD 2021
- Fundamental
- Price
- SLN $6.47
- WALD $3.85
- Analyst Decision
- SLN Strong Buy
- WALD Strong Buy
- Analyst Count
- SLN 4
- WALD 4
- Target Price
- SLN $61.50
- WALD $5.95
- AVG Volume (30 Days)
- SLN 959.2K
- WALD 123.1K
- Earning Date
- SLN 11-14-2024
- WALD 08-27-2024
- Dividend Yield
- SLN N/A
- WALD N/A
- EPS Growth
- SLN N/A
- WALD N/A
- EPS
- SLN N/A
- WALD N/A
- Revenue
- SLN $21,773,221.00
- WALD $240,382,000.00
- Revenue This Year
- SLN N/A
- WALD $27.44
- Revenue Next Year
- SLN $104.98
- WALD $19.55
- P/E Ratio
- SLN N/A
- WALD N/A
- Revenue Growth
- SLN N/A
- WALD N/A
- 52 Week Low
- SLN $5.81
- WALD $2.41
- 52 Week High
- SLN $27.72
- WALD $12.00
- Technical
- Relative Strength Index (RSI)
- SLN 27.24
- WALD 66.63
- Support Level
- SLN $6.06
- WALD $3.73
- Resistance Level
- SLN $8.88
- WALD $4.18
- Average True Range (ATR)
- SLN 0.72
- WALD 0.21
- MACD
- SLN 0.22
- WALD 0.08
- Stochastic Oscillator
- SLN 22.52
- WALD 78.29
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It is organized into two reportable segments namely Obagi Skincare and Milk Makeup.